Navigation Links
Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences
Date:3/3/2009

Infectious Diseases Company Featured on March 9th and 10th, 2009, at BioSquare Meeting in France, and March 17, 2009, at BioEurope in Italy

ROCKVILLE, Md., March 3 /PRNewswire/ -- Sequella, Inc., a clinical-stage biopharmaceutical company focused on commercializing products for infectious diseases of epidemic potential has announced that Alan Klein, Sequella Executive Vice President for Corporate Development, will participate in a Panel at the BioSquare 2009 Meeting at the Lyon Congress Center in Lyon, France. The Panel, entitled New Antibiotherapies for Tomorrow, will be held from 10:45 AM to 12:00 noon on March 9, 2009. The presentation will address antibiotic strategies of the 21st century and highlights both the most advanced and successful approaches and the characteristics of future opportunities.

Mr. Klein will also present at the same meeting on Tuesday, March 10, from 10:15 to 11:00 AM in Room St. Clair 2, 2nd floor, as part of the CNS & Infectious Diseases section of BioSquare 2009 at the Lyon Congress Center in Lyon, France.

Sequella will also present on March 17, 2009 at 5:00 PM in Room Yellow 3, Level 1, of the Infectious Diseases section at BioEurope Spring 2009 at the Milano Convention Centre in Milan, Italy.

"We look forward to participating in both of these European conferences and presenting new information regarding the progress of our product portfolio, while continuing partnership discussions that will appropriately monetize our assets," said Mr. Klein. To learn more about Sequella or their presentations at BioSquare or the BioEurope Spring conference, visit www.sequella.com.

About Sequella

Sequella is a clinical stage biopharmaceutical company focused on commercializing im
'/>"/>

SOURCE Sequella, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Dr. John Stephen Osika, HIV/AIDS and Infectious Disease Expert, Joins Abt Associates
2. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
3. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
4. New Company to Develop Nutritional Interventions Against Chronic Inflammatory and Infectious Diseases
5. Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract
6. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
7. Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents
8. Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
9. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
10. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
11. Collaborative Software Initiative Addresses State Governments Requirements for Meeting Infectious Disease Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
...CET, AMSTERDAM, February 20 Amsterdam Molecular,...d of human gene therapy,today reported its full ye..., raising gross proceeds of EUR 55.7 million - Ca...30, 2007 - U.S. FDA orphan drug designation for l.../II in LPL type I deficiency - Pre-registration t...
...emonstrated by a collaboration between researchers...logy (NIST), Penn State and the University of Kent...duce large arrays of organic electronic transistor...ns including flexible displays, intelligent paper ...diagnostics. , In a paper posted this week,* the ...
...ion,(Nasdaq: KNSY ) is scheduled to present at th... at the Mission Bay Conference Center in San,Franc..., Kensey Nash,s Chief Operating Officer, will deli...ately at 2:50 p.m. (PT). The,presentation material...p://www.kenseynash.com ) beginning at 2:50 p.m. (P...
Other Biology Technology:Amsterdam Molecular Therapeutics Reports Full Year Results 2007 2Amsterdam Molecular Therapeutics Reports Full Year Results 2007 3Amsterdam Molecular Therapeutics Reports Full Year Results 2007 4Amsterdam Molecular Therapeutics Reports Full Year Results 2007 5Amsterdam Molecular Therapeutics Reports Full Year Results 2007 6Amsterdam Molecular Therapeutics Reports Full Year Results 2007 7Directed self-ordering of organic molecules for electronic devices 2
(Date:12/3/2009)Grand Rapids, Mich. (Dec. 3, 2009) Van Andel Research Institute (VARI) researchers have determined precisely how the plant hormone abscisic acid (ABA) works at the molecular level to help plants re
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)UPTON, NY A team of scientists from the U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Harvard University, and the Indian Institute of Science has made a major step in understandin
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 1Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 2Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives 5403 3News brief 3A Effects of aspirin and folic acid on inflammation markers for colorectal adenomas 59312 1Drop in Certain Visual Skills May Precede Alzheimers 59310 1Drop in Certain Visual Skills May Precede Alzheimers 59310 2
...pression of genes may be the reason why people who...ckly develop a tolerance, biologists at The Univer...eam, led by graduate student Yan Wang, used the fr...to determine how the nervous system becomes tolera...The team,s work appears in the October 16 issue of...
...ore acid, with potentially devastating consequence...eefs and provide much of the Earths breathable oxy...up of carbon dioxide (CO 2 ) in the atmosphere, di... be lethal for animals with chalky skeletons which...ife. , Acid oceans will be among the issues explo...
...DED BROKERAGE TO UTILIZE TITANIUM,S ... Oct. 16 Titanium Group, Ltd,(OTC Bulletin Board:...s,provider announced today that it has signed a co...) (SHA: 600837). Titanium will install its,Biometr...ated office in,Hong Kong. Haitong, listed in the S...
Other Biology News:Tolerance to inhalants may be caused by changes in gene expression 2Acid oceans warning 2Titanium Group Announces Contract With Haitong Securities 2Titanium Group Announces Contract With Haitong Securities 3Titanium Group Announces Contract With Haitong Securities 4
Mouse Anti-Human ACP2 Monoclonal Antibody, Unconjugated, Clone M1-4A12 from Novus Biologicals
Mouse Anti-Human DCAMKL2 Monoclonal Antibody, Unconjugated, Clone 2A5 from Novus Biologicals
...ew IKATUBE ULTRA TURRAX Tube Disperser System from... system. It offers a cleaner, safer, and more effi...processes sample volumes from 2 to 15 ml inside se...chers can choose one of 4 different tube types. Ea...
...ewest member of Wyatt Technology's family of light...our high temperature chromatograph and enables you...rmoplastic polymers. The HTmD is easily installed ... 2000 device and enables you to get three angles o...
Biology Products: